Comprehensive Biochemistry Study Notes on Protein Structure, Enzymatic Catalysis, Acid-Base Equilibria, and Clinical Buffering Systems

Fundamentals of Biochemistry and Clinical Relevance

• Definition of Biochemistry: The application of chemical principles to explain biological processes at the molecular level. An understanding of biochemistry serves as an essential foundation for all life sciences, including pharmacy and medicine.

• Biochemical Basis of Disease:

  • The origin, progression, and management of diseases require a detailed understanding of underlying biochemical pathways.

  • Disruptions or deficiencies in metabolic pathways produce specific genetic or acquired metabolic disorders (for example, Phenylketonuria [PKU] caused by missing pathway enzymes).

  • Dysregulation of pathway control mechanisms leads to proliferative cellular diseases (for example, cancer characterized by uncontrolled cell division).

  • Pathogenic invasion by microorganisms (bacteria, fungi, viruses, and parasites) alters host biochemistry; drug development relies on targeting microbial pathways selectively while sparing host tissues.

  • Examples of major viral pathogens emerging over recent decades include HIV, COVID-19, Ebola, and Marburg virus.

• Six Major Pharmacological Drug Targets:

  • Small molecule therapeutic drugs typically target six primary biological structures:

  • Enzymes

  • Cell surface receptors

  • Nuclear hormone receptors

  • Ion channels

  • Transporters

  • DNA

• Drug Actions and Unintended Consequences:

  • Understanding drug mechanisms of action and side effects requires biochemistry.

  • Metabolic interactions involving the cytochrome P450 (P450) enzyme family (via enzyme inhibition or induction by drugs or food) can lead to significant drug-drug interactions.

• Core Topics in Pharmaceutical Biochemistry:

  • Acid-base disorders, PKU, acetaminophen and glutathione detoxification, diabetes and insulin, semaglutide (Ozempic and Wegovy), botulinum toxin (botox), protein misfolding diseases, sickle cell anemia, acetylcholinesterase inhibitors and nerve agents, penicillin, $\beta$-lactamases and antibiotic resistance, ACE inhibitors, HIV protease inhibitors, vitamins, hemoglobin $\text{A}_{1\text{c}}$ ($\text{HbA}_{1\text{c}}$), glycolysis, and the Warburg effect in cancer.

Macromolecular Structure and Function: Proteins and Nucleic Acids

• Protein Hierarchy and Structural Progression:

  • Amino Acids: Small building blocks used by living organisms to construct peptides and proteins. The human body utilizes 20 main amino acids in various sequence combinations to produce thousands of distinct proteins, including enzymes, structural muscle proteins, peptide hormones, and antibodies.

  • Peptides: Short chains of amino acids covalently linked by peptide bonds (amide bonds).

  • Dipeptides: Chains consisting of 2 amino acid residues.

  • Tripeptides: Chains consisting of 3 amino acid residues.

  • Oligopeptides: Chains consisting of 4 to 20 amino acid residues.

  • Polypeptides: Long chains consisting of greater than 20 amino acid residues ($>20$).

  • Sequence Progression:     $\text{Amino Acids} \rightarrow \text{Dipeptides} \rightarrow \text{Tripeptides} \rightarrow \text{Oligopeptides} \rightarrow \text{Polypeptides} \rightarrow \text{Proteins}$

• Four Levels of Protein Structure:

  • Primary Structure: The linear sequence of amino acids linked together by covalent peptide bonds. Extends from the N-terminus (amino group end) to the C-terminus (carboxyl group end).

  • Secondary Structure: Localized folding patterns maintained by hydrogen bonding along the polypeptide backbone between carboxyl and amino groups. Primary types include:

  • $\alpha$-Helix: Spiral, coiled structural arrangement.

  • $\beta$-Pleated Sheet: Folded, sheet-like structural arrangement.

  • Tertiary Structure: The overall three-dimensional folded conformation of a single polypeptide chain, created by folding $\alpha$-helices, $\beta$-pleated sheets, and unstructured loop regions together. The specific 3D shape directly dictates functional activity.

  • Quaternary Structure: The spatial arrangement and assembly of multiple individual polypeptide chains (two or more subunits) into a functional multi-subunit protein complex.

• Conjugated Proteins:

  • Proteins that contain non-protein chemical components termed prosthetic groups.

  • Organic Prosthetic Groups:

  • Glycoprotein: Protein combined with a carbohydrate group.

  • Lipoprotein: Protein combined with a lipid group.

  • Nucleoprotein: Protein combined with a nucleic acid.

  • Inorganic Prosthetic Groups:

  • Hemoglobin: Protein combined with inorganic iron ($\text{Fe}$).

• Nucleic Acids:

  • DNA (Deoxyribonucleic Acid): Contains deoxyribose sugar. Stores genetic instructions required for cellular protein expression. Structurally double-stranded in a double-helix configuration. Nitrogenous bases include Adenine ($\text{A}$), Thymine ($\text{T}$), Cytosine ($\text{C}$), and Guanine ($\text{G}$). Base pairing rules: $\text{A}-\text{T}$ and $\text{C}-\text{G}$.

  • RNA (Ribonucleic Acid): Contains ribose sugar. Facilitates the utilization of genetic information stored in DNA to synthesize proteins. Structurally single-stranded. Nitrogenous bases include Adenine ($\text{A}$), Uracil ($\text{U}$), Cytosine ($\text{C}$), and Guanine ($\text{G}$). Base pairing rules: $\text{A}-\text{U}$ and $\text{C}-\text{G}$.

Enzymes, Kinetics, and Peptide Bond Hydrolysis

• Principles of Enzymatic Catalysis:

  • Most enzymes present in biological systems are functional proteins synthesized by living organisms to serve as biological catalysts.

  • Catalyst Definition: Any agent that accelerates the rate of a chemical reaction without undergoing permanent chemical change or being consumed in the reaction.

  • Core Distinction: All enzymes are catalysts, but not all catalysts are enzymes.

  • Kinetic and Thermodynamic Characteristics:

  • Catalysts accelerate chemical reaction rates by lowering the activation energy barrier.

  • Catalysts do not alter the equilibrium position ($K_{\text{eq}}$) of a chemical reaction.

  • Catalysts are non-thermodynamic agents; they do not change the overall Gibbs free energy change ($\Delta G$).

  • Enzyme activity and structural stability are sensitive to changes in solution $\text{pH}$ and temperature.

• Peptide Stability vs. Enzymatic Breakdown:

  • Biological Function vs. Digestion: Peptides require structural stability to execute functional biological roles. In contrast, digestion requires controlled peptide bond breakdown.

  • Hydrolysis Mechanism: Peptide bond cleavage occurs via hydrolysis (the addition of a water molecule, $\text{H}_2\text{O}$), catalyzed by hydrolytic enzymes.

  • Chemical Splitting Process:

  • Hydrogen ($\text{H}^+$) attaches to the amide nitrogen atom ($\text{N}$).

  • Hydroxyl ($\text{OH}^-$) attaches to the carbonyl carbon atom ($\text{C}$).

  • Breaks the peptide bond (amide bond) connecting amino acid residues, producing separate amino acid units containing free amino ($\text{H}_2\text{N}-\text{C}(\text{R})$) and carboxyl ($-\text{COOH}$) terminal groups.

Cell Signaling Pathways and Surface Receptor Mechanisms

• Signal Classification by Action Distance:

  • Autocrine Signals: Signaling molecules released by a cell that bind directly to receptors on the surface of the same cell.

  • Paracrine Signals: Signaling molecules released into the immediate extracellular space that target nearby adjacent cells.

  • Endocrine Signals: Signaling molecules secreted into the circulatory system to travel extended distances throughout the organism to reach target cells (for example, systemic hormones circulating in blood, or cytokines released at injury sites traveling to the brain to produce fever).

• Ligand Physical Properties and Receptor Interaction:

  • Receptors: Specialized protein structures designed to bind specific signaling molecules (ligands) to deliver biochemical messages.

  • Hydrophobic Ligands: Non-polar, water-repelling molecules capable of diffusing directly across the fatty lipid membrane of target cells. They bind to intracellular receptors located inside the cytoplasm or nucleus and travel through aqueous blood attached to transport carrier proteins.

  • Hydrophilic Ligands: Polar, water-soluble molecules unable to cross the lipophilic interior of the cell membrane. They bind to specialized cell-surface receptors located on the exterior plasma membrane to initiate biological responses.

• Three Stages of Cellular Receptor Action:

  1. Reception: The specific binding interaction between a ligand and its receptor.

  2. Transduction: Conformational transformation of the receptor protein that transfers the chemical signal across the membrane into the cell.

  3. Cellular Response: Downstream activation of intracellular biochemical cascades and effector mechanisms.

• Three Primary Classes of Cell-Surface Receptors:

  1. G-Protein Coupled Receptors (GPCRs): Transmembrane receptors that pass back and forth through the cell membrane 7 times.

  • Heterotrimeric G-Protein Subunits: Associated with a three-part intracellular protein consisting of $\alpha$ (Alpha), $\beta$ (Beta), and $\gamma$ (Gamma) subunits ($\text{G-protein} = \alpha + \beta + \gamma$).

  • Primary G-Protein Subtypes:

    • $G_q$: Activates the membrane enzyme Phospholipase C.

    • $G_s$: Stimulates Adenylate Cyclase (Adenylase cyclase) to increase cyclic AMP levels.

    • $G_i$: Inhibits Adenylate Cyclase to decrease cyclic AMP levels.

  • Signal Sequence: Hydrophilic ligand binds extracellular domain of GPCR $\rightarrow$ GPCR undergoes conformational change activating internal G-protein ($\alpha, \beta, \gamma$) $\rightarrow$ active G-protein subunit carries signal forward inside cell $\rightarrow$ cell executes physiological response.

  1. Enzyme-Coupled Receptors: Single-pass transmembrane receptors possessing intrinsic enzyme activity or directly activating linked internal enzymes upon extracellular ligand binding.

  2. Ion-Channel Receptors: Cell surface channels that open or close upon ligand binding to facilitate passive flow of specific inorganic ions across the membrane (such as $\text{Cl}^-$, $\text{Ca}^{2+}$, $\text{Na}^+$, and $\text{K}^+$).

Acid-Base Chemistry Principles and Definitions

• Chemical Protons and Ionization States:

  • Many biological molecules contain functional groups capable of acting as acids (releasing protons) or bases (accepting protons).

  • Ionization and electrical charge states depend on environmental $\text{pH}$. These charges determine molecular solubility, physiological structure, and pharmacokinetic drug distribution (charged species enhance aqueous solubility; uncharged species promote passive membrane permeation).

• Brønsted-Lowry Definitions:

  • Brønsted-Lowry Acid: A chemical species that donates a proton ($\text{H}^+$) to solution.

  • Brønsted-Lowry Base: A chemical species that accepts a proton ($\text{H}^+$) from solution.

  • Amphoteric Compounds: Chemical species capable of functioning as either an acid or a base depending on reaction conditions (for example, $\text{H}_2\text{O}$).

  • Conjugate Reaction Examples:     $\text{H}_2\text{O (base)} + \text{H}_2\text{O (acid)} \rightleftharpoons \text{H}_3\text{O}^+ \text{(conjugate acid)} + \text{OH}^- \text{(conjugate base)}$     $\text{NH}_3 \text{(base)} + \text{HCl (acid)} \rightarrow \text{NH}_4^+ \text{(conjugate acid)} + \text{Cl}^- \text{(conjugate base)}$

• Strong Acids versus Weak Acids:

  • Strong Acids: Ionize almost completely in aqueous solution ($\text{H}_2\text{O}$).

  • Generates a high concentration of free $\text{H}^+$, producing highly acidic solutions.

  • Reaction equilibrium ($K_{\text{eq}}$) strongly favors products.

  • Acid dissociation constant $K_a \gg 1$.

  • Seven Key Strong Acids: Hydrochloric acid ($\text{HCl}$), Hydrobromic acid ($\text{HBr}$), Hydroiodic acid ($\text{HI}$), Nitric acid ($\text{HNO}_3$), Sulfuric acid ($\text{H}_2\text{SO}_4$), Perchloric acid ($\text{HClO}_4$), and Chloric acid ($\text{HClO}_3$).

  • Complete dissociation formula:       $\text{HCl} \rightarrow \text{H}^+ + \text{Cl}^-$

  • Weak Acids: Partially dissociate/ionize in aqueous solution.

  • Generates low free $\text{H}^+$ concentrations.

  • Reaction equilibrium favors undissociated reactant molecules.

  • Acid dissociation constant $K_a \ll 1$ (where $K_a \approx K_{\text{eq}}$).

  • Representative examples include Hydrofluoric acid ($\text{HF} \rightleftharpoons \text{H}^+ + \text{F}^-$) and Acetic acid ($\text{CH}_3\text{CO}_2\text{H} \rightleftharpoons \text{CH}_3\text{CO}_2^- + \text{H}^+$). All organic acids not included in the seven strong acids are classified as weak acids.

Quantitative pH, pOH, Ka, and pKa Relationships

• The $\text{pH}$ Scale:

  • Expresses free hydrogen ion concentration ($[\text{H}^+]$) in molarity ($\text{M} = \text{mol/dm}^3$).

  • Standard formula:     $\text{pH} = -\log([\text{H}^+])$

  • Conversion formula to calculate concentration:     $[\text{H}^+] = 10^{-\text{pH}}$

  • Inverse Logarithmic Behavior: Lower $\text{pH}$ values indicate higher $\text{H}^+$ concentrations (greater acidity); higher $\text{pH}$ values indicate lower $\text{H}^+$ concentrations (lower acidity/greater basicity).

  • Logarithmic Scale Factors: A change of $1\,\text{unit}$ in $\text{pH}$ represents a $10\text{-fold}$ change in free $[\text{H}^+]$.

  • A shift from $\text{pH}\,7$ to $\text{pH}\,8$ represents a $10\text{-fold}$ reduction in $[\text{H}^+]$.

  • A solution at $\text{pH}\,2$ contains $10^3 = 1000\text{ times}$ more free $\text{H}^+$ ions than a solution at $\text{pH}\,5$.

  • Physiological Range: Most human biological reactions take place between $\text{pH}\,6.5$ and $\text{pH}\,8.0$. Normal human blood $\text{pH}$ is maintained at $7.40$.

• The $\text{pOH}$ Scale:

  • Quantifies hydroxide ion concentration ($[\text{OH}^-]$).

  • Standard formulas:     $\text{pOH} = -\log([\text{OH}^-])$     $\text{pOH} = 14 - \text{pH}$

  • Relationship at $25\,^\circ\text{C}$:     $\text{pH} + \text{pOH} = 14$

• Acid Dissociation Constant ($K_a$) and $\text{p}K_a$:

  • For weak acid dissociation $\text{HA} \rightleftharpoons \text{H}^+ + \text{A}^-$:     $K_a = \frac{[\text{H}^+][\text{A}^-]}{[\text{HA}]}$

  • $[\text{A}^-]$ represents the concentration of conjugate base remaining after proton release.

  • Larger $K_a$ values signify stronger acids.

  • $\text{p}K_a$ Definition:     $\text{p}K_a = -\log(K_a)$

  • Lower $\text{p}K_a$ values signify stronger acids.

  • Numerical Example: If $K_a = 1 \times 10^{-3}$, then $\text{p}K_a = 3$. If $K_a = 1 \times 10^{-6}$, then $\text{p}K_a = 6$. An acid with $\text{p}K_a = 3$ is significantly stronger than an acid with $\text{p}K_a = 6$.

The Henderson-Hasselbalch Equation and Buffer Dynamics

• Henderson-Hasselbalch Equation:

  • Standard equation:     $\text{pH} = \text{p}K_a + \log\left(\frac{[\text{conjugate base}]}{[\text{acid}]}\right) = \text{p}K_a + \log\left(\frac{[\text{A}^-]}{[\text{HA}]}\right)$

  • Practical Uses: Estimating buffer solution $\text{pH}$, determining the ratio of conjugate base to weak acid ($[\text{A}^-]/[\text{HA}]$), or calculating amounts of acid and conjugate base required to formulate a buffer at a specific $\text{pH}$.

  • Key Equilibrium Relationships:

  • When $[\text{A}^-] = [\text{HA}]$, the ratio is $1$, $\log(1) = 0$, and $\text{pH} = \text{p}K_a$ ($50\%$ dissociated, $50\%$ undissociated).

  • When $\text{pH} > \text{p}K_a$, conjugate base concentration exceeds acid concentration ($[\text{A}^-] > [\text{HA}]$).

  • When $\text{pH} < \text{p}K_a$, weak acid concentration exceeds conjugate base concentration ($[\text{HA}] > [\text{A}^-]$).

  • At $1\,\text{pH unit}$ above $\text{p}K_a$ ($\text{ratio} = 10/1$), the mixture contains $\sim 90.9\%$ conjugate base and $\sim 9.09\%$ undissociated weak acid.

• Practice Calculation Examples:

  • Example 1: Given $\text{pH} = 3.75$ and $\text{p}K_a = 4.72$, calculate the ratio $[\text{A}^-]/[\text{HA}]$:     $3.75 = 4.72 + \log(x)$     $\log(x) = 3.75 - 4.72 = -0.97$     $x = 10^{-0.97} \approx 0.1072$     (Because $\text{pH} < \text{p}K_a$, undissociated acid $\text{HA}$ exceeds conjugate base $\text{A}^-$).

  • Example 2: Given $\text{p}K_a = 4$, $[\text{Base}] = 1\,\text{M}$, $[\text{Acid}] = 1\,\text{M}$:     $\text{pH} = 4 + \log\left(\frac{1}{1}\right) = 4 + 0 = 4$

  • Example 3: Given $\text{p}K_a = 4$, $[\text{Base}] = 10\,\text{M}$, $[\text{Acid}] = 1\,\text{M}$:     $\text{pH} = 4 + \log\left(\frac{10}{1}\right) = 4 + 1 = 5$

  • Example 4: Given $\text{p}K_a = 4$, $[\text{Base}] = 1\,\text{M}$, $[\text{Acid}] = 10\,\text{M}$:     $\text{pH} = 4 + \log\left(\frac{1}{10}\right) = 4 + (-1) = 3$

• $\text{p}K_a$ Determination via Titration:

  • Experimental Procedure: Measured quantities of a strong base (supplying $\text{OH}^-$) are titrated incrementally into a weak acid solution ($\text{HA}$), while monitoring $\text{pH}$.

  • Neutralization Reaction:     $\text{HA} + \text{OH}^- \rightarrow \text{A}^- + \text{H}_2\text{O}$

  • Titration Trajectory: Adding $\text{OH}^-$ lowers $[\text{HA}]$, raises $[\text{A}^-]$, and increases overall $\text{pH}$.

  • Midpoint Determination: When exactly $0.5\,\text{equivalent}$ of base is added, half of $\text{HA}$ is converted to $\text{A}^-$ ($[\text{HA}] = [\text{A}^-]$). The observed $\text{pH}$ at this titration midpoint equals the experimentally determined $\text{p}K_a$.

  • Monoprotic vs. Polyprotic Titrations:

  • Monoprotic acids (e.g., acetic acid) contain $1$ ionizable proton, require $1\,\text{equivalent}$ of $\text{OH}^-$ for full titration, and display $1\,\text{p}K_a$ value.

  • Polyprotic acids (e.g., phosphoric acid, $\text{H}_3\text{PO}_4$) contain multiple ionizable protons, require $3\,\text{equivalents}$ of base for complete titration, and display $3$ distinct $\text{p}K_a$ values across 4 chemical species ($\text{H}_3\text{PO}_4$, $\text{H}_2\text{PO}_4^-$, $\text{HPO}_4^{2-}$, and $\text{PO}_4^{3-}$).

  • At physiological $\text{pH}\,7.4$, the predominant inorganic phosphate species are $\text{H}_2\text{PO}_4^-$ and $\text{HPO}_4^{2-}$; concentrations of $\text{H}_3\text{PO}_4$ and $\text{PO}_4^{3-}$ are negligible because $\text{pH}\,7.4$ is greater than 2 units away from their respective $\text{p}K_a$ values.

Physiological Buffer Systems and Clinical Acid-Base Disorders

• Buffer Principles and Buffer Capacity:

  • Buffer Solution: A mixture consisting of a weak acid and its conjugate base that resists drastic shifts in $\text{pH}$ upon addition of small amounts of strong acid or base.

  • Effective Buffering Range: Generally spans $1\,\text{pH unit}$ below to $1\,\text{pH unit}$ above the weak acid's $\text{p}K_a$ ($\text{p}K_a \pm 1$).

  • Buffer Capacity: Refers to the total combined concentration of weak acid plus conjugate base ($[\text{HA}] + [\text{A}^-]$). Higher concentrations yield higher buffer capacity (for example, a $100\,\text{mM}$ buffer resists $\text{pH}$ changes better than a $10\,\text{mM}$ buffer).

  • Buffer Types:

  • Acidic Buffers ($\text{pH} < 7$): Composed of a weak acid and its strong conjugate base.

  • Basic Buffers ($\text{pH} > 7$): Composed of a weak base and its strong conjugate acid.

• Physiological Blood $\text{pH}$ Regulation:

  • Normal Arterial Blood $\text{pH}$: Tightly controlled at $7.40$ (physiological range $7.35 - 7.45$).

  • Acidemia / Acidosis: Blood \text{pH} < 7.35$.\n * Alkalemia / Alkalosis: Blood \text{pH} > 7.45$.

  • Primary Extracellular Buffer: Carbon dioxide - carbonic acid - bicarbonate system ($\text{CO}_2 - \text{H}_2\text{CO}_3 - \text{HCO}_3^-$) working alongside hemoglobin.

  • Primary Intracellular Buffers: Intracellular proteins and inorganic phosphate ($\text{H}_2\text{PO}_4^- / \text{HPO}_4^{2-}$).

  • Bicarbonate System Reversible Reaction:     $\text{CO}_2 + \text{H}_2\text{O} \stackrel{\text{Carbonic Anhydrase}}{\rightleftharpoons} \text{H}_2\text{CO}_3 \rightleftharpoons \text{H}^+ + \text{HCO}_3^-$

  • Organ Regulation: Lungs regulate dissolved and gaseous $\text{CO}_2$ levels via ventilation; kidneys regulate plasma bicarbonate ($\text{HCO}_3^-$) levels via tubular reabsorption and excretion.

• Pathophysiological Acid-Base Disturbances and Compensation:

  • Respiratory Acidosis:

  • Etiology: Hypoventilation caused by chronic obstructive lung disease, pulmonary obstruction, or excessive administration of narcotics, sedatives, or anesthetics.

  • Mechanism: Accumulation of $\text{CO}_2$ elevates $\text{H}_2\text{CO}_3$ and $\text{H}^+$, driving blood \text{pH} < 7.35$.\n * Compensation: Kidneys increase renal reabsorption and retention of bicarbonate (\text{HCO}_3^-$) to raise blood$\text{pH}.\n * Respiratory Alkalosis:\n * Etiology: Hyperventilation triggered by anxiety, severe head injury, or central nervous system disorders (such as meningitis, encephalitis, or cerebral hemorrhage).\n * Mechanism: Excessive exhalation of \text{CO}_2$depletes blood$\text{H}_2\text{CO}_3$, raising blood$\text{pH} > 7.45$.

  • Compensation: Kidneys decrease renal reabsorption of bicarbonate ($\text{HCO}_3^-$), excreting $\text{HCO}_3^-$ to lower blood $\text{pH}$.

  • Metabolic Acidosis:

  • Etiology: Severe bicarbonate loss (due to severe diarrhea), buildup of metabolic ketoacids (in uncontrolled diabetes mellitus), or toxic poisonings (such as aspirin overdose).

  • Mechanism: Depletion of plasma $\text{HCO}_3^-$ lowers blood \text{pH} < 7.35$, leading to relative \text{H}_2\text{CO}_3 excess.\n * Compensation: Immediate respiratory hyperventilation (rapid breathing) to eliminate gaseous \text{CO}_2 and remove acid load.\n * Metabolic Alkalosis:\n * Etiology: Severe loss of gastric stomach acid (\text{HCl}) from persistent vomiting, or ingestion of large doses of alkaline sodium bicarbonate coupled with renal impairment.\n * Mechanism: Depletion of acid elevates plasma \text{HCO}_3^-$and blood$\text{pH} > 7.45$.

  • Compensation: Immediate respiratory hypoventilation (slowed breathing) to retain $\text{CO}_2$ and build up carbonic acid.